Inherited coagulation disorders in Turkish children: A retrospective, single-center cohort study

Autor: Ülker Koçak, Zühre Kaya, Türkiz Gürsel, Melek Isik, Idil Yenicesu, Ebru Yılmaz Keskin, Nergiz Öner, Burcu Belen Apak, Meryem Albayrak
Přispěvatelé: KKÜ, Kırıkkale Üniversitesi
Rok vydání: 2020
Předmět:
Zdroj: Transfusion and Apheresis Science. 59:102728
ISSN: 1473-0502
DOI: 10.1016/j.transci.2020.102728
Popis: Albayrak, Meryem/0000-0003-2711-5150 WOS:000538124200008 PubMed: 31980335 Objective: This study aims to investigate the distribution, clinical characteristics and outcome of inherited coagulation disorders (ICD) in Turkish children. Subjects and methods: Data from all children (age < 18 years) with ICD examined in our center were retrospectively reviewed. Results: There were 403 children with ICD (233 males and 170 females) with a median age of four years at diagnosis. The percentages of von Willebrand disease (vWd), hemophilia and rare bleeding disorders (RBD) were 40 %, 34 % and 26 %, type-1, type-2 and type-3 vWd were 63 % 17 % and 20 %, hemophilia A and B were 84 % and 16 %, and severe, moderate and mild hemophilia were 48 %, 30 % and 22 %, respectively. Factor VII and FXI deficiencies were the most prevalent, comprising 56 % and 22 % of all children with RBD, respectively. Parental consanguinity rates were 72 % in type-3 vWd and 61 % in severe RBD. The overall prevalence of gastrointestinal bleedings was 4.5 % (18/403), intracranial bleeding (ICB) was 4.96 % (20/403), mortality from ICB was 30 % (6/20) and the overall mortality rate was 1.49 % (6/403). No life-threatening bleeding was seen during regular prophylaxis. Chronic arthropathy prevalence in severe hemophilia was 8 % with primary prophylaxis and 53 % with demand therap. Inhibitor prevalence was 14 % in hemophilia-A and 5 % in hemophiliaB. Conclusions: These data show that vWd is the most common ICD, type-3 vWd and RBD are prevalent due to frequent consanguineous marriages and diagnosis of ICD is substantially delayed in Turkish children. Prophylactic replacement therapy prevents occurrence of life-threatening bleedings and reduces the development of hemophilic arthropathy.
Databáze: OpenAIRE